effect of boswellia papyrifera on cognitive impairment in multiple sclerosis.

نویسندگان

behnaz sedighi department of neurology, school of medicine, neurology research center, kerman university of medical sciences, kerman, iran.

abbas pardakhty department of pharmacology ,school of pharmacy, pharmaceutics research center, neuropharmacology institute, kerman university of medical sciences, kerman, iran.

hoda kamali department of neurology, school of medicine, neurology research center, kerman university of medical sciences, kerman, iran.

kaveh shafiee department of neurology, school of medicine, neurology research center, kerman university of medical sciences, kerman, iran.

چکیده

background: cognitive  impairment  is one of the  most crucial disorders  among  multiple  sclerosis (ms) patients. since  ms  is  an inflammatory disease   and   boswellia papyrifera has anti-inflammatory effects, the influence of b. papyrifera  on  cognitive  impairment   in  ms patients   has been investigated  in the present study. methods: in this clinical trial, 80 ms patients  who referred to the clinic of shafa hospital, kerman, iran were selected. having completed a written  consent  form, patients  with relapsing remitting ms, with no occurrence of a new attack throughout 1 month  before the study, with no pregnancy or breastfeeding entered the study. the patients  were randomly divided into two groups; then brief international cognitive assessment for ms (bicams) test was carried out. one group received b. papyrifera (capsule 300 mg, twice a day) while the other group received placebo with the same dose  for 2 months. after 2 months  of treatment, bicams was redone  and  changes  were  analyze .the significant change value on the before-after bicams points were considered  to be 8, 13, and 7 points for the symbol digit modality  test (sdmt),  the  california verbal  learning  test (cvlt),  and  the  brief visual-spatial  memory  test  revised (bvmt-r), respectively. results:  the  patients’  mean  age  was 36.58     8.50  years. the mean duration of disease was 7.41    4.13 years. about 84.2% (n = 64) of the patients  was female. in the bvmt-r, 13 patients  (34.2%), who had  already taken  b. papyrifera, were shown to have significant improvement compared  to the  placebo  group  with  no  improvement  (p <  0.  001). about  12 and  8 patients  in the  treatment and  placebo groups in the sdmt, respectively (p = 0.200) and 17 and 12 patients  in the treatment and placebo groups in the cvlt, respectively (p = 0.170) had signi@cant change values. conclusion: b. papyrifera showed significant improvement in  visuospatial  memory,  but   had   no  effect  on  verbal memory and information processing speed.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effect of Boswellia papyrifera on cognitive impairment in multiple sclerosis

BACKGROUND Cognitive impairment is one of the most crucial disorders among multiple sclerosis (MS) patients. Since MS is an inflammatory disease and Boswellia papyrifera has anti-inflammatory effects, the influence of B. papyrifera on cognitive impairment in MS patients has been investigated in the present study. METHODS In this clinical trial, 80 MS patients who referred to the clinic of Sha...

متن کامل

Multiple Sclerosis Cognitive Impairment in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. Although MS has been known since the 19th century, cognitive impairment (CI) was only recognised as an important feature of MS over the past 30 years. The reason is that, until recently, MS was perceived exclusively as a white matter disease, and cognition was thought to depend solely on the ...

متن کامل

[Cognitive impairment in multiple sclerosis].

The various lesions affecting the central nervous system in multiple sclerosis (MS) lead to a wide range of symptoms. Until now, physical disabilities have been the main focus of studies on the symptoms of MS; however, cognitive impairment that prominently affects sustained attention and information processing speed has been found by neuropsychological studies to affect over half of all MS pati...

متن کامل

Cognitive Impairment in Multiple Sclerosis

Article history: Received: 27 May 2012 Accepted: 12 Aug 2012 Available online: 12 Mar 2013 ZJRMS 2014; 16(1): 1-7 Cognitive impairment can emerge in the earliest phases of multiple sclerosis. It strongly impacts different aspects of Multiple Sclerosis (MS) patients' lives, like employment, social relationships and the overall quality of life; thus, its on-time recognition and treatment is manda...

متن کامل

[Pathogenesis of cognitive impairment in multiple sclerosis].

Around a half of multiple sclerosis (MS) patients suffer from cognitive impairment such as attention deficit. A similar impairment is already observable in one third of patients with clinical isolated syndrome, suggesting that the symptom cannot be solely explained by the accumulation of demyelinated lesions. Recently, several studies indicated that demyelination and atrophy in specific regions...

متن کامل

Treatment of Cognitive Impairment in Multiple Sclerosis

Cognitive impairment in multiple sclerosis is an increasingly recognized entity. This article reviews the cognitive impairment of multiple sclerosis, its prevalence, its relationship to different types of multiple sclerosis, and its contribution to long-term functional prognosis. The discussion also focuses on the key elements of cognitive dysfunction in multiple sclerosis which distinguish it ...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
iranian journal of neurology

جلد ۱۳، شماره ۳، صفحات ۱۴۹-۱۵۳

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023